Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples